Oncoscope is now available on iPad

Request free access to get started

News & insights

Resources

Publications

ISPOR 2026

HEOR at the Forefront of Policy, Access, and Value

18 presentations. One mission.

May 17 – 20 2026
Philadelphia, PA

EHA 2026
Advancing personalized management in multiple myeloma: the untapped value of minimal residual disease-guided treatment

Musat M, Rege J, Liu R, et al. Advancing personalized management in multiple myeloma: the untapped value of minimal residual disease-guided treatment [abstract]. HemaSphere. 2026;10(S1):PB3356.

ESMO RWD 2026
Development and Validation of an Agentic AI-Augmented Living Decision Support Tool for Oncology: A Breast Cancer Pilot Study
Rugo H, Forsythe A, Flora D, et al. Development and validation of an agentic AI-augmented living decision support tool for oncology: A breast cancer pilot study. ESMO Real World Data Digital Oncol.
In press

Demos

Oncoscope decision support system
SLR in 2 minutes

How many studies with ADC are in breast cancer

Login

Edge

For physicians seeking patient-level treatment guidance and KOLs shaping the next generation of standards of care.

Enterprise

For pharmaceutical innovators to support strategic decisions and regulatory & reimbursement submissions.